In an IBD mouse model, Bifidobacterium infantis supplementation was able to increase Foxp3, IL-10 and TGF-β1 protein levels, besides alleviating intestinal epithelial injury and maintaining the intestinal immune tolerance [111]. This evidence concerns the gene FOXP3 and inflammatory bowel disease.